Selected Presentations & Appearances
Abstract “Ketamine Infusions for Pain Control in Acute Care: persistent opioid use analysis in medical vs surgical patient population” – presented at International Society for Anaesthetic Pharmacology – Virtual Annual Meeting
· October 2020
Other
Ketamine Infusions for Pain Control in Acute Care: Prevalence of Side Effects
- abstract presentation
· 2019
Other
Annual Meeting of the American Society of Anesthesiologists.
Poster presentation
- Twiddler’s Syndrome
· 2012
Instructional Course, Workshop, or Symposium
SGIM conference
Service to the Profession
Planning committee
- Best Practices in Pain Management
·
2019
Event/Organization Administration
Wake AHEC
Member
- NC DHHS Opioid and Prescription Drug Abuse Advisory Committee (OPDAAC)
·
2018
Committee Service
Planning Committee
- From Contemplation to Action: Best Practices for Treating Pain
·
2018
Event/Organization Administration
Wake AHEC
Member
·
2017
Committee Service
NCHA Coalition for Model Opioid Prescribing (CfMOP)
Academic & Administrative Activities
- Sub-Investigator for STRIVE #2, 7/2023-2024
- Sub-Investigator for Strategies and Treatments for Respiratory Infections &Amp; Viral Emergencies (STRIVE): Shionogi Protease Inhibitor, 3/2023 - 2025
- Sub-Investigator for ACTIV-4c: Post-hospital Thromboprophylaxis : A multicenter, adaptive, prospective, randomized trial evaluating the efficacy and safety of antithrombotic strategies in patients with COVID-19 following hospital discharge, 12/2021 - 6/2022
- Sub-Investigator for ACTIV-4a: A Multicenter, Adaptive, Randomized, Controlled Platform Trial of the Safety and Efficacy of Antithrombotic Strategies in Hospitalized Adults with COVID-19, 11/2021- 5/2023
- Sub-Investigator for Dalbavancin as an Option for Treatment of S. aureus Bacteremia (DOTS): A Phase 2b, Multicenter, Randomized, Open-Label, Assessor-Blinded Superiority Study to Compare the Efficacy and Safety of Dalbavancin to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients with Complicated S. aureus Bacteremia trial, 11/2021 - 2023
- Sub-Investigator for ACTIV-3: Therapeutics for Inpatients With COVID-19 (TICO) trial, 8/2020 – 2022
- Sub-Investigator for Immune Modulators for Treating COVID-19 (ACTIV-1 IM) trial, 11/2020 – 2/2022
- Co-Investigator for EAP COVID convalescent plasma, 7/2020 – 9/2020
Clinical Activities
Hospitalist at Duke Raleigh Hospital